- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04812704
Protein Supplements in Association With Prehabilitation Program for Cancer Patients Before Surgery
Suppléments protéinés en Association d'un Programme de préhabilitation Avant la Prise en Charge Chirurgicale d'un Cancer
The aim of study is to analyse the feasibility of the use of nutritionnal complements after exercices before surgery for cancer.
Body composition, muscle function and muscle mass will be analyse too.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
A prospective study will be carried out including adult patients with neoplasia who should benefit in their therapeutic strategy from oncological surgery. About fifty patients will be recruited in the oncology / surgery department at the Saint-Luc University Clinics in Brussels. Patients will be assessed at the initial consultation and after the pre-habilitation period, ie the day before the operation.
Dietary monitoring will be carried out in parallel with a physical and respiratory preparation program (prehabilitation) and the intake of protein nutritional supplements in the form of powder to be diluted will be carried out after each exercise session.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Brussels, Belgium, 1200
- Cliniques Universitaires Saint-luc
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- patient with operable cancer
- patient inform consent
- min 18 years old
- french or english speaking
Exclusion Criteria:
- neuromuscular pathology
- cardiorespiratory or orthopedic pathology that prevents physical activity
- cognitive or psychiatric disorders
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Nutritional complement
A prospective study will be carried out including adult patients with neoplasia who should benefit in their therapeutic strategy from oncological surgery. About fifty patients will be recruited in the oncology / surgery department at the Saint-Luc University Clinics in Brussels. Patients will be assessed at the initial consultation and after the pre-habilitation period, ie the day before the operation. Dietary monitoring will be carried out in parallel with a physical and respiratory preparation program (prehabilitation) and the intake of protein nutritional supplements in the form of powder to be diluted will be carried out after each exercise session. |
Patient receive protein supplement in liquid form after each exercice session
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adhesion rate of the use of nutritionnel complements after exercices before surgery for cancer
Time Frame: 3 weeks
|
The feasibility of this outcome will be assess by the adhesion rate : (number of protein shots taken) / (number of protein shots prescribed).
The adhesion will be validated if> 75% of the holds are respected.
|
3 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Body composition (lean and fat mass)
Time Frame: Once at the inclusion and once the day before surgery (3 weeks)
|
Evaluated by an impedancemetry balance : pourcentage of lean and fat mass
|
Once at the inclusion and once the day before surgery (3 weeks)
|
|
Muscle function
Time Frame: Once at the inclusion and once the day before surgery (3 weeks)
|
This variable will be studied by the 6-minutes walk test (meters)
|
Once at the inclusion and once the day before surgery (3 weeks)
|
|
Nutritional biological markers
Time Frame: Once at the inclusion
|
These variables will be studied by: prealbumin (g/L) and albumin (g/L) measures
|
Once at the inclusion
|
|
Antropometric markers - height
Time Frame: Once at the inclusion and once the day before surgery (3 weeks)
|
Height (meters)
|
Once at the inclusion and once the day before surgery (3 weeks)
|
|
Muscle strength
Time Frame: Once at the inclusion and once the day before surgery (3 weeks)
|
This variable will be studied by the hand grip test (kilograms)
|
Once at the inclusion and once the day before surgery (3 weeks)
|
|
Antropometric markers - weight
Time Frame: Once at the inclusion and once the day before surgery (3 weeks)
|
Weight (kilograms)
|
Once at the inclusion and once the day before surgery (3 weeks)
|
|
Antropometric markers - BMI
Time Frame: Once at the inclusion and once the day before surgery (3 weeks)
|
BMI (kg/m²) :weight and height will be combined to report BMI in kg/m²
|
Once at the inclusion and once the day before surgery (3 weeks)
|
Collaborators and Investigators
Investigators
- Principal Investigator: Yannick Deswysen, MD, Cliniques Universitaires Saint-luc
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2021/19JAN/022
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
University of Michigan Rogel Cancer CenterCompletedCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); Atrium Health Wake Forest BaptistRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
Vanderbilt-Ingram Cancer CenterEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
University of California, San FranciscoBristol-Myers Squibb; PfizerTerminatedStage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Metastatic Colorectal Adenocarcinoma | Metastatic Colon Adenocarcinoma | Metastatic Rectal Adenocarcinoma | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Stage IV Colon Cancer | Stage IV Rectal... and other conditionsUnited States
-
Yale UniversityNational Institute of Nursing Research (NINR); The Glimpse Group IncRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
Palleon Pharmaceuticals, Inc.CompletedMelanoma | Cancer | Breast Cancer | Head and Neck Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | NSCLC | Non Small Cell Lung Cancer | Bladder Cancer | Colon Cancer | Urothelial Cancer | Oncology | CRC | Esophagogastric Junction Cancer | EGJUnited States
-
University of California, San DiegoWithdrawnCervical Cancer | Cervical Cancer Stage | Cervical Cancer Stage IB2 | Cervical Cancer Stage IB1 | Cervical Cancer Stage I | Cervical Cancer Stage IB | Cervical Cancer Stage II | Cervical Cancer Stage IIa | Cervical Cancer, Stage IIB | Cervical Cancer, Stage III | Cervical Cancer Stage IIIB | Cervical Cancer... and other conditionsUnited States
-
MiRXES Pte LtdRecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Thoracic Cancer | Liver CancerSingapore
Clinical Trials on Whey protein
-
The University of Texas Medical Branch, GalvestonMeiji Co., Ltd.Completed
-
McMaster UniversityCanadian Institutes of Health Research (CIHR); University of California, Davis and other collaboratorsCompletedRegulation of Muscle Protein SynthesisCanada
-
Sports Performance and Applied Research in Trials...RecruitingRecovery | Muscle Strength | Sports Nutritional Sciences | Supplements | Muscle Strength RecoveryUnited Kingdom
-
Efforia, IncActive, not recruiting
-
Musclegen Research, Inc.CompletedAbsorption; Disorder, Protein | Analysis, Event History
-
University of NottinghamCompletedAssessing the Impact of "Super-whey" vs. Isonitrogenous Whey on Muscle Protein Synthesis (ARLA-WHEY)SarcopeniaUnited Kingdom
-
University of ReginaIovate Health Sciences International IncRecruiting
-
Skidmore CollegeCompletedObesity | OverweightUnited States
-
Wenshan City People's HospitalNot yet recruitingIschemic Stroke | Traumatic Brain Injury | Neurocritical Conditions
-
Peking Union Medical College HospitalNot yet recruiting